Researchers in Texas began studying the impact of these therapies in 2007, after seeing the success of Gleevec (imatinib) -- a breakthrough drug approved by US regulators in 2001 that showed huge success against chronic myeloid leukemia.from Top Lifestyle News- News18.com https://ift.tt/2JfOZWA
Comments
Post a Comment